Emma Carrick
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
-
- Immune Response and Inflammation
- interferon and immune responses
Papers in
-
- Ubiquitin and proteasome pathways 2
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Hilary A. Smith (2 shared papers)Mark Peggie (2 shared papers)Philip Cohen (2 shared papers)Nick Morrice (1 shared paper)Alban Ordureau (1 shared paper)Mark Windheim (1 shared paper)Franck Vandermoere (1 shared paper)Anthony D. Whetton (3 shared papers)
- Journals
- PROTEOMICS - CLINICAL APPLICATIONS (2 papers)Cell Reports Physical Science (1 paper)Nature Communications (1 paper)Frontiers in Immunology (1 paper)Biochemical Journal (1 paper)
- Partner nations
- United KingdomGermanyFrance
In The Last Decade
Emma Carrick
14 papers receiving 562 citations
Peers
Comparison fields: 5 of 102
- Hematology 111
- Immunology 174
- Cancer Research 112
- Genetics 64
- Molecular Biology 253
Countries citing papers authored by Emma Carrick
This map shows the geographic impact of Emma Carrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Carrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Carrick more than expected).
Fields of papers citing papers by Emma Carrick
This network shows the impact of papers produced by Emma Carrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Carrick. The network helps show where Emma Carrick may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Carrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 165 | |
| 2 | 2007 | 142 | |
| 3 | 2021 | 94 | |
| 4 | 2009 | 61 | |
| 5 | 2018 | 43 | |
| 6 | 2020 | 12 | |
| 7 | 2016 | 12 | |
| 8 | 2018 | 10 | |
| 9 | 2016 | 9 | |
| 10 | 2012 | 9 | |
| 11 | Dopa-responsive dystonia (Segawa syndrome). | 2006 | 5 |
| 12 | 2021 | 3 | |
| 13 | 2021 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2013 | 0 |
About Emma Carrick
Emma Carrick is a scholar working on Molecular Biology, Oncology, Spectroscopy, Cancer Research and Genetics, having authored 15 papers that have together received 568 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), interferon and immune responses (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Advanced Proteomics Techniques and Applications (2 papers), NF-κB Signaling Pathways (2 papers), Mass Spectrometry Techniques and Applications (2 papers), Ubiquitin and proteasome pathways (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hematology (111 citations), Immunology (174 citations), Cancer Research (112 citations), Genetics (64 citations) and Molecular Biology (253 citations). Emma Carrick has collaborated with scholars based in United Kingdom, Germany and France. Frequent co-authors include Hilary A. Smith, Mark Peggie, Philip Cohen, Nick Morrice, Alban Ordureau, Mark Windheim, Franck Vandermoere, Anthony D. Whetton, David G. Campbell and David Vetrie. Their work appears in journals such as PROTEOMICS - CLINICAL APPLICATIONS, Cell Reports Physical Science, Nature Communications, Frontiers in Immunology and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.